Ron J. Keizer
Impact in
- Transplantation top 5%
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Statistical Methods in Clinical Trials 10
-
- Antibiotics Pharmacokinetics and Efficacy 9
- Co-authors
- Jos H. Beijnen (16 shared papers)Alwin D. R. Huitema (16 shared papers)Jan H.M. Schellens (13 shared papers)Srijib Goswami (11 shared papers)Adam Frymoyer (4 shared papers)Rob ter Heine (8 shared papers)Robert S. Jansen (2 shared papers)Hilde Rosing (2 shared papers)
- Journals
- Clinical Pharmacokinetics (9 papers)CPT Pharmacometrics & Systems Pharmacology (4 papers)British Journal of Clinical Pharmacology (4 papers)Investigational New Drugs (3 papers)Journal of Pharmaceutical Sciences (3 papers)
- Partner nations
- NetherlandsUnited StatesSweden
In The Last Decade
Ron J. Keizer
58 papers receiving 2.0k citations
Ron J. Keizer's Hit Papers
Peers
Comparison fields: 5 of 125
- Transplantation 66
- Pharmacology 286
- Pharmacology 128
- Statistics and Probability 116
- Immunology 236
Countries citing papers authored by Ron J. Keizer
This map shows the geographic impact of Ron J. Keizer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron J. Keizer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron J. Keizer more than expected).
Fields of papers citing papers by Ron J. Keizer
This network shows the impact of papers produced by Ron J. Keizer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron J. Keizer. The network helps show where Ron J. Keizer may publish in the future.
Co-authors
The 25 scholars most cited alongside Ron J. Keizer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies Hit paper breakdown → | 2010 | 566 |
| 2 | 2010 | 285 | |
| 3 | 2015 | 157 | |
| 4 | 2008 | 120 | |
| 5 | 2018 | 88 | |
| 6 | 2015 | 57 | |
| 7 | 2010 | 57 | |
| 8 | 2020 | 52 | |
| 9 | 2015 | 48 | |
| 10 | 2017 | 43 | |
| 11 | 2021 | 41 | |
| 12 | 2020 | 36 | |
| 13 | 2012 | 34 | |
| 14 | 2020 | 31 | |
| 15 | 2020 | 30 | |
| 16 | 2013 | 25 | |
| 17 | 2020 | 23 | |
| 18 | 2008 | 21 | |
| 19 | 2010 | 20 | |
| 20 | 2019 | 19 |
About Ron J. Keizer
Ron J. Keizer is a scholar working on Statistics and Probability, Pharmacology, Hematology, Pediatrics, Perinatology and Child Health and Oncology, having authored 60 papers that have together received 2.0k indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (10 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers), Renal Transplantation Outcomes and Treatments (5 papers), Hematopoietic Stem Cell Transplantation (4 papers), Pharmaceutical studies and practices (4 papers), Inflammatory Bowel Disease (4 papers), Microfluidic and Capillary Electrophoresis Applications (3 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Transplantation (66 citations), Pharmacology (286 citations), Pharmacology (128 citations), Statistics and Probability (116 citations) and Immunology (236 citations). Ron J. Keizer has collaborated with scholars based in Netherlands, United States and Sweden. Frequent co-authors include Jos H. Beijnen, Alwin D. R. Huitema, Jan H.M. Schellens, Srijib Goswami, Adam Frymoyer, Rob ter Heine, Robert S. Jansen, Hilde Rosing, Bas Thijssen and Peter J. de Vries. Their work appears in journals such as Clinical Pharmacokinetics, CPT Pharmacometrics & Systems Pharmacology, British Journal of Clinical Pharmacology, Investigational New Drugs and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.